Publication

Article

Pharmacy Times

Volume00

LONG-TERM WARFARIN USE MAY INCREASE RISK OF FRACTURES IN MEN

A study of Medicare beneficiaries with atrial fibrillation whowere hospitalized between March 1998 and April 1999throughout the country found that men who were on longterm(defined as >1 yr) warfarin therapy were 63% more likelyto suffer an osteoporosis-related fracture of the hip, spine,or wrist.Women on long-term therapy and patients who tookthe drug for <1 year had no significant increase in risk.

Vitamin K is involved in the activation of bone proteins.Warfarin's inhibition of this activation process because ofvitamin K antagonism may explain why patients on long-term therapy face anincreased risk of osteoporosis. The study also found that patients who were onbeta-blockers or who had high dietary intake of vitamin K and folate had adecreased risk of fractures.

Dr. Garrett is a clinical pharmacist practitionerat Cornerstone Health Care in HighPoint, NC.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs